Filed before 2025Filed 30 April 2021
Treeline Biosciences, Inc. raised $212M
Treeline Biosciences, Inc., a biotech company based in Stamford, CT, raised $212M in a new equity round, according to a filing dated 30 April 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 30 April 2021
- Round
- Equity round
- Amount sold
- $212M
- Offering size
- $220M
- Investors so far
- 34
- Based in
- Stamford, CT
- Website
- treeline.bio
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 97% of the 2,220 tracked raises with an amount filed in 2021, and than 98% of the 177 in biotech.
Treeline Biosciences, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 4 Sep 2025 | New filing | $200M | Another raise |
| 17 Oct 2024 | New filing | $422M | Another raise |
| 11 Oct 2022 | New filing | $261M | Another raise |
| 30 Apr 2021 | New filing | $212M | This raise |
More with ARCH on the board
- SonoThera, Inc.$125M
- Ollin Biosciences, Inc.$156M
- Vizgen, Inc.$47.8M
- Pheast Therapeutics, Inc.$24.6M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.